SCHEMBL21153755

SCHEMBL21153755

CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)COC(=O)CCC(=O)O)O1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 10/20 0.77
▸ PGR P06401 6/20 0.77
▸ HIF1A Q16665 4/20 0.77
▸ CYP3A4 P08684 3/20 0.77
▸ LMNA P02545 3/20 0.77
▸ ABCC3 O15438 1/20 0.77
▸ ABCC4 O15439 1/20 0.77
▸ ABCB11 O95342 1/20 0.77
▸ IL5 P05113 1/20 0.77
▸ NR3C2 P08235 1/20 0.77
▸ AR P10275 1/20 0.77
▸ CHRM1 P11229 1/20 0.77
▸ MMP9 P14780 1/20 0.77
▸ NFKB1 P19838 1/20 0.77
▸ THPO P40225 1/20 0.77
▸ SMN1; SMN2 Q16637 1/20 0.77
▸ HSD17B10 Q99714 1/20 0.77
▸ BLM P54132 1/20 0.77
▸ PMP22 Q01453 1/20 0.77
▸ NPSR1 Q6W5P4 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14965919 1.00 NR3C1 (0.77) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL21152598 1.00 NR3C1 (0.77) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL21153523 1.00 NR3C1 (0.77) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL30987798 0.94 NR3C1 (0.77) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL5396842 0.93 NR3C1 (0.81) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL19583464 0.93 NR3C1 (0.76) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL3305265 0.93 NR3C1 (0.76) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL18051174 0.93 NR3C1 (0.76) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL19583457 0.93 NR3C1 (0.76) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL4448853 0.92 NR3C1 (0.82) NR3C1PGRHIF1ACYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019217591-A1 ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2019-11-14 — — WO disclosed
WO-2019136487-A2 STEROIDS AND ANTIBODY-CONJUGATES THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2019-07-11 — — WO disclosed
Send feedback